Project GENIE, a registry of real-world genomic and clinical cancer data, has announced a 5-year, $36 million collaboration with nine biopharmaceutical companies to obtain detailed information from at least 50,000… Click to show full abstract
Project GENIE, a registry of real-world genomic and clinical cancer data, has announced a 5-year, $36 million collaboration with nine biopharmaceutical companies to obtain detailed information from at least 50,000 patients, which would be added to the 70,000 cases already in Project GENIE's database.
               
Click one of the above tabs to view related content.